Skip to main content
. 2022 Apr 23;47(6):631–640. doi: 10.1093/jpepsy/jsac036

Table I.

Patient Populations Included in CEFIS-AYA Validation

Patient group Number of sites Number of participants
Hematology/oncology/stem cell transplant 4 260
Community 3 1,687
Pain 3 550
Primary care 2 491
Diabetes 2 41
Irritable bowel syndrome 2 11
Students with chronic conditions 1 492
Spina bifida 1 308
Eating disorders 1 57
Genomic medicine 1 13
HIV 1 2